Definium Therapeutics (DFTX) Debt Ratio (2023 - 2026)

Definium Therapeutics (DFTX) has 4 years of Debt Ratio data on file, last reported at 0.1 in Q1 2026.

• On a quarterly basis, Debt Ratio rose 26.95% year-over-year to 0.1 in Q1 2026; TTM through Mar 2026 was 0.1, a 26.95% increase from a year earlier, with the FY2025 full-year figure at 0.09, up 27.48% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.1, up from 0.09 in the prior quarter.
• Over the last five years, Debt Ratio for DFTX reached as high as 0.17 in Q3 2025 and fell as low as 0.05 in Q1 2024.
• Historically, Debt Ratio has averaged 0.1 across 4 years, with a median of 0.09 in 2025.
• Across the five-year window, Debt Ratio plunged 36.25% in 2024 and surged 124.21% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 0.11 in 2023, then slumped by 36.25% to 0.07 in 2024, then gained by 27.48% to 0.09 in 2025, then gained by 10.19% to 0.1 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.1 in Q1 2026, 0.09 in Q4 2025, and 0.17 in Q3 2025.